Quality of life among multiple sclerosis patients in Saudi Arabia

References

1. ↵
   1. Compston A,
   2. Coles A

   (2008) Multiple sclerosis. Lancet 372, 1502–1517.
2. ↵
   1. Olsson T,
   2. Barcellos LF,
   3. Alfredsson L

   (2017) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 13, 25–36.
3. ↵
   1. Confavreux C,
   2. Vukusic S

   (2006) Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment. Clin Neurol Neurosurg 108, 327–332.
4. ↵
   1. Karussis D

   (2014) The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun 48-49, 134–142.
5. ↵
   1. Mitosek-szewczyk K,
   2. Kułakowska A,
   3. Bartosik-psujek H,
   4. Hożejowski R,
   5. Drozdowski W,
   6. Stelmasiak Z

   (2014) Quality of life in Polish patients with multiple sclerosis. Adv Med Sci 59, 34–38.
6. ↵
   1. Aburuz S,
   2. Bulatova N,
   3. Twalbeh M,
   4. Gazawi M

   (2009) The validity and reliability of the Arabic version of the EQ-5D: a study from Jordan. Ann Saudi Med 29, 304–308.
7. ↵
   1. Reenen MV,
   2. Janssen B

   (2015) EQ-5D-5L User Guide Basic information on how to use the EQ-5D-5L instrument (EuroQol Research Foundation, The Netherlands) Available at: https://euroqol.org/wp-content/uploads/2016/09/EQ-5D-5L_UserGuide_2015.pdf.
8. ↵
   1. van Hout B,
   2. Janssen MF,
   3. Feng YS,
   4. Kohlmann T,
   5. Busschbach J,
   6. Golicki D,
   7. et al.

   (2012) Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 15, 708–715.
9. ↵
   1. Al-Tahan AM,
   2. Al-Jumah MA,
   3. Bohlega SM,
   4. Al-Shammari SN,
   5. Al-Sharoqi IA,
   6. Dahdaleh MP,
   7. et al.

   (2011) The importance of quality-of-life assessment in the management of patients with multiple sclerosis. Recommendations from the Middle East MS Advisory Group. Neurosciences (Riyadh) 16, 109–113.
10. ↵
    1. Kes VB,
    2. Cengić L,
    3. Cesarik M,
    4. Tomas AJ,
    5. Zavoreo I,
    6. Matovina LZ,
    7. et al.

    (2013) Quality of life in patients with multiple sclerosis. Acta Clin Croat 52, 107–111.
11. ↵
    1. Göksel karatepe A,
    2. Kaya T,
    3. Günaydn R,
    4. Demirhan A,
    5. Ce P,
    6. Gedizlioğlu M

    (2011) Quality of life in patients with multiple sclerosis: the impact of depression, fatigue, and disability. Int J Rehabil Res 34, 290–298.
12. ↵
    1. Baumstarck K,
    2. Boyer L,
    3. Boucekine M,
    4. Michel P,
    5. Pelletier J,
    6. Auquier P

    (2013) Measuring the quality of life in patients with multiple sclerosis in clinical practice: a necessary challenge. Mult Scler Int 2013, 524894.
13. ↵
    1. Chen K,
    2. Fan Y,
    3. Hu R,
    4. Yang T,
    5. Li K

    (2013) Impact of depression, fatigue and disability on quality of life in Chinese patients with multiple sclerosis. Stress Health 29, 108–112.
14. ↵
    1. Truini A,
    2. Barbanti P,
    3. Pozzilli C,
    4. Cruccu G

    (2013) A mechanism-based classification of pain in multiple sclerosis. J Neurol 260, 351–367.
15. ↵
    1. Nick ST,
    2. Roberts C,
    3. Billiodeaux S,
    4. Davis DE,
    5. Zamanifekri B,
    6. Sahraian MA,
    7. et al.

    (2012) Multiple sclerosis and pain. Neurol Res 34, 829–841.
16. ↵
    1. Kenner M,
    2. Menon U,
    3. Elliott DG

    (2007) Multiple sclerosis as a painful disease. Int Rev Neurobiol 79, 303–321.
17. ↵
    1. Lily O,
    2. Mcfadden E,
    3. Hensor E,
    4. Johnson M,
    5. Ford H

    (2006) Disease-specific quality of life in multiple sclerosis: the effect of disease modifying treatment. Mult Scler 12, 808–813.